Lessons From Primary Cardiac Prevention Trials During Trastuzumab Therapy: End of One Size Fits All

Ana Barac, Anne Blaes, Filipa Lynce

Research output: Contribution to journalArticle

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)2869-2871
Number of pages3
JournalJournal of the American College of Cardiology
Volume73
Issue number22
DOIs
StatePublished - Jun 11 2019

Keywords

  • breast cancer
  • cardiotoxicity
  • ejection fraction
  • heart failure
  • trastuzumab

Cite this